May 22, 2023Open Access

Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes

Key points are not available for this paper at this time.

ClinicalTrials.gov Identifier: NCT03985293.

AI에게 질문

Bookmark

View Full Paper

AI에게 질문

Bookmark

View Full Paper

Cite This Study